Description
Riesgo de extravasación con necrosis tisular
Uso bajo prescripción médica estricta
No se recomienda durante la lactancia
Dosis habitual: 600 mg una vez al día con inhibidor de la proteasa booster (como ritonavir o cobicistat)
CO-APROVEL 150/12.5 MG 28 TAB NEBULIZADOR 1.00 PZA Riesgo de extravasación con necrosisPRINCIPIO ACTIVO: IRBESARTAN HIDROCLOROTIAZIDA 150 MG DOSIS: 12. 5 MG FORMA FARMACUTICA: 28 TABLETAS PRESENTACIN: 1 CAJA
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
